Ustar Biotechnology, based in Hangzhou, China, is a molecular diagnostic company dedicated to developing, manufacturing, and marketing rapid nucleic acid diagnostic products for point-of-care. The company hold...
Ustar Biotechnology, based in Hangzhou, China, is a molecular diagnostic company dedicated to developing, manufacturing, and marketing rapid nucleic acid diagnostic products for point-of-care. The company holds fifteen China, U.S., Japan patents for novel molecular technologies, including disposable nucleic acid(NA) extraction device, cross-priming isothermal amplification (CPA), disposable contamination-proof DNA detection device, and reagent glassification. Combining them, Ustar offers pathogen NA detection platforms and SNP/Mutation detection platform that can be transformed into rapid molecular diagnostic kits for Point-of-Care diagnostics or on-spot testing. The isothermal testing requires no PCR machine and molecular lab, enabling molecular testing possible in the low-resources setting with quick results. Several diagnostics had been developed for the detection of TB, TB multidrug-resistance (TB-MDR), STD, etc. Applications cover hospital, CDC and Import & Export Quarantines, etc.Ustar's main office and manufacturing facilities are located in Binjiang District, Hangzhou, China. The new 2,000 square meters facilities includes a 800 square meters 100K grade clean room area, with a designed production capacity of 20 million tests per year. The facility is constructed and equipped with state-of-the-art technology and is ISO9001:2003, ISO13485:2003 + AC: 2007 certified.
"We love the interface, the experience, and most importantly… the results."
Erik Straub
Chief Marketing Officer, Kickfurther
"Using Apollo, we’ve solved the biggest problem for every business, the lead problem. We are now constrained by sales time and no longer lack interested prospects."
Michael Transon
CEO, Victorious
Ready to try it out?
Get started for free, then add your whole team. You can always talk to sales if you’re interested in advanced plans.